TellBio Amends Exempt Offering Notice (Form D/A) on March 24, 2026

TL;DR

**TellBio just updated its private funding details, so keep an eye on their capital strategy.**

AI Summary

TellBio, Inc. filed a D/A (amended Form D) on March 24, 2026, updating its Notice of Exempt Offering of Securities. This filing, with SEC Accession No. 0001791842-26-000001, indicates a change or correction to a previous exempt offering. For investors, this matters because it provides updated information about how TellBio is raising capital outside of traditional public offerings, which can impact future dilution or funding stability.

Why It Matters

This amendment provides updated details on TellBio's private fundraising efforts, which is crucial for understanding the company's capital structure and potential future stock dilution.

Risk Assessment

Risk Level: medium — While an amendment itself isn't inherently risky, changes to exempt offerings can signal shifts in funding strategy or terms, which could impact existing shareholders.

Analyst Insight

Investors should monitor subsequent filings or company announcements for details on the specific changes made in this D/A, as they could impact valuation or future funding rounds.

Key Numbers

• 2026-03-24 — Filing Date (The date TellBio, Inc. filed the D/A form.)
• 0001791842-26-000001 — SEC Accession No. (Unique identifier for this specific SEC filing.)
• 021-527206 — File No. (The file number associated with the original exempt offering.)

Key Players & Entities

• TellBio, Inc. (company) — the filer of the D/A form
• 0001791842 (company) — the CIK (Central Index Key) for TellBio, Inc.
• DE (company) — State of Incorporation for TellBio, Inc.
• 842769345 (company) — EIN (Employer Identification Number) for TellBio, Inc.

Forward-Looking Statements

• TellBio, Inc. will likely continue to utilize private offerings for capital raises. (TellBio, Inc.) — medium confidence, target: 2027-03-24

FAQ

Key Financial Figures

• $1 — enues   No Aggregate Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,
• $1,000,000 — No Aggregate Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,
• $5,000,000 — Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,000   $5,000,001
• $1,000,001 — e   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,000   $5,000,001 - $25,000,000
• $5,000,001 — $5,000,000   $1,000,001 - $5,000,000   $5,000,001 - $25,000,000 $5,000,001 - $25,000,000
• $25,000,000 — $1,000,001 - $5,000,000   $5,000,001 - $25,000,000 $5,000,001 - $25,000,000   $25,000,001
• $25,000,001 — $25,000,000 $5,000,001 - $25,000,000   $25,000,001 - $50,000,000 $25,000,001 - $100,000,0
• $50,000,000 — 5,000,001 - $25,000,000   $25,000,001 - $50,000,000 $25,000,001 - $100,000,000   $50,000,0
• $100,000,000 — 25,000,001 - $50,000,000 $25,000,001 - $100,000,000   $50,000,001 - $100,000,000   Over $1
• $50,000,001 — 0,000,000 $25,000,001 - $100,000,000   $50,000,001 - $100,000,000   Over $100,000,000   O

Filing Documents

• primary_doc.html (D/A)
• primary_doc.xml (D/A) — 6KB
• 0001791842-26-000001.txt ( ) — 7KB

From the Filing

Form D FORM D Notice of Exempt Offering of Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. OMB APPROVAL OMB Number: 3235-0076 Estimated Average burden hours per response: 4.0 1. Issuer's Identity CIK (Filer ID Number) Previous Name(s) None Entity Type Corporation Limited Partnership   Limited Liability Company   General Partnership   Business Trust Other   Name of Issuer   TellBio, Inc. Jurisdiction of Incorporation/Organization DELAWARE   Year of Incorporation/Organization Over Five Years Ago Within Last Five Years (Specify Year)   Yet to Be Formed           2. Principal Place of Business and Contact Information Name of Issuer   TellBio, Inc. Street Address 1 Street Address 2   19 CONNECTOR RD   SUITE 4   ANDOVER   MASSACHUSETTS     01810   781-249-9550   3. Related Persons Last Name First Name Middle Name PETERS RICHARD Street Address 1 Street Address 2   123 CRANE NECK STREET       WEST NEWBURY   MASSACHUSETTS   01985   Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary)   Last Name First Name Middle Name CROCKER GARY Street Address 1 Street Address 2   2825 E COTTONWOOD PARKWAY     SUITE 330   SALT LAKE CITY   UTAH   84121   Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary)   Last Name First Name Middle Name PETERS BERNARD Street Address 1 Street Address 2   1933 W OAKDALE AVENUE       CHICAGO   ILLINOIS   60657   Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary)   4. Industry Group   Agriculture Banking & Financial Services     Commercial Banking     Insurance   Investing     Investment Banking     Pooled Investment Fund   Other Banking & Financial Services   Business Services Energy     Coal Mining     Electric Utilities     Energy Conservation     Environmental Services     Oil & Gas     Other Energy Health Care     Biotechnology     Health Insurance     Hospitals & Physicians     Pharmaceuticals     Other Health Care                         Manufacturing Real Estate   Commercial   Construction   REITS & Finance   Residential Other Real Estate   Retailing Restaurants Technology   Computers   Telecommunications   Other Technology Travel   Airlines & Airports   Lodging & Conventions   Tourism & Travel Services   Other Travel Other        5. Issuer Size Revenue Range Aggregate Net Asset Value Range No Revenues   No Aggregate Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,000   $5,000,001 - $25,000,000 $5,000,001 - $25,000,000   $25,000,001 - $50,000,000 $25,000,001 - $100,000,000   $50,000,001 - $100,000,000   Over $100,000,000   Over $100,000,000   Decline to Disclose   Decline to Disclose   Not Applicable   Not Applicable   6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply) Rule 504(b)(1) (not (i), (ii) or (iii)) Rule 506(b)         Rule 504 (b)(1)(i) Rule 506(c) Rule 504 (b)(1)(ii) Securities Act Section 4(a)(5) Rule 504 (b)(1)(iii) Investment Company Act Section 3(c)     7. Type of Filing   New Notice Date of First Sale   2024-09-04   First Sale Yet to Occur   Amendment     8. Duration of Offering Does the Issuer intend this offering to last more than one year?   Yes   No     9. Type(s) of Securities Offered (select all that apply) Pooled Investment Fund Interests Equity Tenant-in-Common Securities Debt Mineral Property Securities Option, Warrant or Other Right to Acquire Another Security Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security Other (describe)       10. Business Combination Transaction Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?   Yes   No Clarification of Response (if Necessary)       11. Minimum Investment Minimum investment accepted from any outside investor $   0 USD 12. Sales Compensation Recipient   Recipient CRD Number None     (Associated) Broker or Dealer None (Associated) Broker or Dealer CRD Number  None     Street Address 1 Street Address 2             13. Offering and Sales Amounts   Total Offering Amount $ 1000000 USD Indefinite Total Amount Sold $ 1000000 USD Total Remaining to be Sold $ 0 USD Indefinite Clarification of Response (if Necessary) The due date for payment of the purchase price of convertible notes was accelerated in exchange for the issuance of warrants.   14. Investors Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors, Number of such non-accredited investors who already have invested in the offering       Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited invest

View Full Filing

View this D/A filing on SEC EDGAR